Balance Labs, Inc. BLNC
$1.55
-$0.02-1.27%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 46.00K | 38.70K | 6.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.00K | 38.70K | 6.00K | -- | -- |
| Cost of Revenue | 13.73M | 13.32M | 12.89M | 326.30K | 190.30K |
| Gross Profit | -13.69M | -13.28M | -12.89M | -326.30K | -190.30K |
| SG&A Expenses | 249.30K | 237.70K | 217.80K | 106.80K | 115.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.98M | 13.55M | 13.11M | 433.20K | 305.80K |
| Operating Income | -13.94M | -13.51M | -13.11M | -433.20K | -305.80K |
| Income Before Tax | -31.67M | -31.58M | -31.77M | -3.86M | -463.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.67 | -31.58 | -31.77 | -3.86 | -0.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.67M | -31.58M | -31.77M | -3.86M | -463.00K |
| EBIT | -13.94M | -13.51M | -13.11M | -433.20K | -305.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.91 | -0.91 | -0.92 | -0.18 | -0.02 |
| Normalized Basic EPS | -0.31 | -0.30 | -0.30 | -0.11 | -0.02 |
| EPS Diluted | -0.91 | -0.91 | -0.92 | -0.18 | -0.02 |
| Normalized Diluted EPS | -0.31 | -0.30 | -0.30 | -0.11 | -0.01 |
| Average Basic Shares Outstanding | 153.25M | 128.07M | 102.89M | 87.03M | 86.70M |
| Average Diluted Shares Outstanding | 153.31M | 128.14M | 107.17M | 91.30M | 90.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |